Claritev Corporation (CTEV)

Market Cap	279.92M -24.6%
Revenue (ttm)	978.76M +5.5%
Net Income	-286.52M
EPS	-17.33
Shares Out	17.05M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,115,045
Open	12.91
Previous Close	13.87
Day's Range	11.50 - 18.40
52-Week Range	11.50 - 74.07
Beta	0.77
Analysts	Buy
Price Target	43.60 (+165.53%)
Earnings Date	May 7, 2026

About CTEV

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical neg...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1980
• Employees: 3,000
• Stock Exchange: NYSE
• Ticker Symbol: CTEV
• Website: https://www.claritev.com

Financial Performance

In 2025, Claritev's revenue was $965.41 million, an increase of 3.74% compared to the previous year's $930.62 million. Losses were -$284.28 million, -82.73% less than in 2024.

Analyst Summary

According to 5 analysts, the average rating for CTEV stock is "Buy." The 12-month stock price target is $43.6, which is an increase of 165.53% from the latest price.

Price Target

$43.6

(165.53% upside)

Analyst Consensus: Buy